Characteristics in patients with ischaemic stroke/systemic embolism
| Patient no. | Age, years | Sex | CHADS2 score | Antithrombotic therapy | Prior documented AF | AHREs detected during follow-up | Progression to persistent AF | AHREs detected ≤30 days before ischaemic stroke/SE |
| 1 | 69 | F | 2 | ASA | – | – | ||
| 2 | 73 | M | 3 | None | – | – | ||
| 3 | 78 | M | 2 | None | – | – | ||
| 4 | 82 | F | 3 | ASA | – | – | ||
| 5 | 87 | F | 4 | None | – | − | ||
| 6 | 75 | F | 3 | ASA | – | + | – | – |
| 7 | 75 | F | 3 | ASA | – | + | − | – |
| 8 | 76 | F | 2 | None | + | + | − | – |
| 9 | 83 | M | 3 | None | – | + | – | – |
| 10 | 84 | F | 3 | ASA | + | + | – | – |
| 11 | 87 | F | 6 | None | – | + | – | – |
| 12 | 67 | M | 5 | ASA | + | + | – | + |
| 13 | 79 | F | 4 | OAC/ASA | + | + | – | + |
| 14 | 76 | M | 3 | OAC | + | + | + | + |
| 15 | 77 | M | 4 | None | + | + | + | + |
| 16 | 80 | F | 5 | OAC/ASA | + | + | + | + |
| 17 | 82 | F | 3 | OAC/ASA | + | + | + | + |
| 18 | 83 | M | 5 | ASA | + | + | + | + |
| 19 | 87 | F | 3 | None | + | + | + | + |
AF, atrial fibrillation; AHREs, atrial high rate episodes; ASA, aspirin; F, female; M, male; OAC, oral anticoagulant; SE, systemic embolism.